In contrast, uncontrolled tumor growth of PD-L1+ SKOV3 cells was observed in the mice treated with low-affinity HER2 CAR-T cells (Fig. 7f), indicating that PD-L1 significantly impaired the antitumor activity of low-affinity HER2 CAR-T cells. This evidence concerns the gene ERBB2 and neoplasm.